Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study

Aim: To examine the association of proton pump inhibitor (PPI) use with subsequent hip fracture incidence in hip fracture patients, accounting for gender, age, PPI doses, PPI initiation before or after first fracture, and year from first fracture in which the first subsequent fracture occurred. Meth...

Full description

Bibliographic Details
Main Authors: Wolfgang Brozek, Berthold Reichardt, Jochen Zwerina, Hans Peter Dimai, Klaus Klaushofer, Elisabeth Zwettler
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:Bone Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187219300105